Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beuzeboc

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancerM Jouve, T Dorval, V Mosseri, et al.
Cancer|April 1, 1996
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimenK Fizazi, B Asselain, A Vincent-Salomon, et al.
American Journal of Clinical Oncology|October 1, 1996
Phase II trial of decapeptyl (D-TRP-6), a potent luteinizing hormone-releasing hormone analogue in untreated advanced breast cancerE Garcia-Giralt, P Beuzeboc, V Dieras, et al.
Bulletin Du Cancer|July 27, 1999
[Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?]P Beuzeboc, S Scholl, X S Garau, et al.
Clinical and Experimental Rheumatology|October 6, 1997
Systemic lupus erythematosus paraneoplastic syndromeP Blanche, P Beuzeboc, A L Vincens, et al.
The Journal of Infusional Chemotherapy|July 1, 1996
First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancerE Garcia-Giralt, P Beuzeboc, D Deffontaines, et al.
Annales De Chirurgie|January 1, 1993
[Malignant epidermoid degeneration of dermoid cysts of the ovary. Apropos of 2 cases]P Beuzeboc, T Dorval, G Mathieu, et al.
Bulletin Du Cancer|November 21, 2000
[How to finance chemotherapy with new cancer drugs?A Livartowski, P Beuzeboc, B Le Vu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association]M Peyromaure, P Beuzeboc, L Salomon, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancerM Jouve, T Dorval, V Mosseri, et al.
Cancer|April 1, 1996
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimenK Fizazi, B Asselain, A Vincent-Salomon, et al.
American Journal of Clinical Oncology|October 1, 1996
Phase II trial of decapeptyl (D-TRP-6), a potent luteinizing hormone-releasing hormone analogue in untreated advanced breast cancerE Garcia-Giralt, P Beuzeboc, V Dieras, et al.
Bulletin Du Cancer|July 27, 1999
[Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?]P Beuzeboc, S Scholl, X S Garau, et al.
Clinical and Experimental Rheumatology|October 6, 1997
Systemic lupus erythematosus paraneoplastic syndromeP Blanche, P Beuzeboc, A L Vincens, et al.
The Journal of Infusional Chemotherapy|July 1, 1996
First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancerE Garcia-Giralt, P Beuzeboc, D Deffontaines, et al.
Annales De Chirurgie|January 1, 1993
[Malignant epidermoid degeneration of dermoid cysts of the ovary. Apropos of 2 cases]P Beuzeboc, T Dorval, G Mathieu, et al.
Bulletin Du Cancer|November 21, 2000
[How to finance chemotherapy with new cancer drugs?A Livartowski, P Beuzeboc, B Le Vu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association]M Peyromaure, P Beuzeboc, L Salomon, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
Pageof 14